New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. MU
4. DPZ
5. ACN
6. NAVN
7. DFTX
8. IBM
9. META
10. ENRD

Go back to New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 --0 (-0%)
Previous Close $344.72    52 Week High $176.85 
Open $344.72    52 Week Low $133.64 
Day High $344.72    P/E 51.92 
Day Low $344.72    EPS $6.64 
Volume 5,459